Company Profiles

driven by the PitchBook Platform

ReViral

ReViral
2011 FOUNDED
PRIVATE STATUS
Series A LATEST DEAL TYPE
$21.1M LATEST DEAL AMOUNT
$22.1M TOTAL AMOUNT RAISED
4 INVESTORS
Description

Developer of antiviral drugs designed to help patients and enlarge the antiviral market by developing novel first-in-class compounds. The company's antiviral drugs is a fusion inhibitor of RSV which is a highly potent, novel small molecule and is being developed to treat RSV in patients with severe disease including neonates, enabling patients to be treated who are infected with respiratory syncytial virus (RSV) by developing novel compounds.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Primary Office
Stevenage Bioscience Catalyst
Gunnels Wood Road
Stevenage SG1 2FX
England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ReViral’s full profile, request a free trial.

ReViral Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 08-Sep-2015 $21.1M $22.1M Completed Startup
1. Angel (individual) 03-Dec-2014 000 000 Completed Startup
To view this company’s complete deal history including valuation and funding request access »

ReViral Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Brace Pharma Capital Corporate Venture Capital Minority 000 0000 000000 0
Edmond de Rothschild Investment Partners PE/Buyout Minority 000 0000 000000 0
OrbiMed Venture Capital Minority 000 0000 000000 0
Wellcome Trust Limited Partner Minority 000 0000 000000 0

ReViral Executive Team (7)

Name Title Board
Seat
Contact
Info
Eddy Littler Ph.D Chief Executive Officer & Board Member
Khatereh Ahmadi Ph.D Co-Founder, Chief Executive Officer & Board Member
Max Herrmann Chief Financial Officer
Rachel Harland Ph.D Chief Operating Officer
Stuart Cockerill Ph.D Co-Founder, Chief Scientific Officer & Board Member
You’re viewing 5 of 7 executives. Get the full list »

ReViral Board Members (7)

Name Representing Role Since Contact
Info
Chau Khuong OrbiMed Board Member 000 0000
Eddy Littler Ph.D ReViral Chief Executive Officer & Board Member 000 0000
Iain Dukes Ph.D Self Board Member 000 0000
Khatereh Ahmadi Ph.D ReViral Co-Founder, Chief Executive Officer & Board Member 000 0000
Raphael Wisniewski Edmond de Rothschild Investment Partners Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »